Eli Lilly has announced positive study results for its first pill aimed at treating diabetes and aiding weight loss. The drug shows promise in addressing both conditions effectively, marking a significant advancement in the pharmaceutical sector. This development could potentially revolutionize treatment options for millions of people globally who suffer from diabetes and obesity. Further studies are planned to confirm the drug’s efficacy and safety before it is made widely available.
— new from WSJ